AGILE THERAPEUTICS INC Annual Operating Income (Loss) in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Agile Therapeutics Inc quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2023.
  • Agile Therapeutics Inc Operating Income (Loss) for the quarter ending June 30, 2024 was -$2.75M, a 46.4% increase year-over-year.
  • Agile Therapeutics Inc Operating Income (Loss) for the twelve months ending June 30, 2024 was -$13.6M, a 63.8% increase year-over-year.
  • Agile Therapeutics Inc annual Operating Income (Loss) for 2023 was -$19.9M, a 62.2% increase from 2022.
  • Agile Therapeutics Inc annual Operating Income (Loss) for 2022 was -$52.6M, a 26% increase from 2021.
  • Agile Therapeutics Inc annual Operating Income (Loss) for 2021 was -$71M, a 44.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$19.9M +$32.7M +62.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 -$52.6M +$18.4M +26% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 -$71M -$22M -44.8% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-28
2020 -$49.1M -$30.2M -160% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-23
2019 -$18.9M +$677K +3.47% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-30
2018 -$19.5M +$7.28M +27.1% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 -$26.8M +$2.91M +9.79% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-20
2016 -$29.7M +$3.37M +10.2% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-12
2015 -$33.1M -$14.6M -78.7% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
2014 -$18.5M -$5.79M -45.5% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-15
2013 -$12.7M +$10.6M +45.4% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-09
2012 -$23.3M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.